Ohcanbohtosat - Yu, Xue-zhong

Aiddostahte ozu
  1. 1
    IL-17A ≠ Th17 in GvHD

    IL-17A ≠ Th17 in GvHD Dahkki Wu, Yongxia, Yu, Xue-Zhong

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Modelling CAR-T therapy in humanized mice

    Modelling CAR-T therapy in humanized mice Dahkki Wu, Yongxia, Yu, Xue-Zhong

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Editorial: Pathogenesis and Therapy of Graft-versus-Host Disease

    Editorial: Pathogenesis and Therapy of Graft-versus-Host Disease Dahkki Betts, Brian C., Yu, Xue-Zhong

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Ethylenecarbodiimide-coupled allogeneic antigen presenting cells induce human CD4(+) regulatory T cells

    Ethylenecarbodiimide-coupled allogeneic antigen presenting cells induce human CD4(+) regulatory T cells Dahkki Albert, Michael H., Yu, Xue-Zhong, Magg, Thomas

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Targeting PKCθ in alloreactivity and graft-versus-host-disease: unanswered questions and therapeutic potential

    Targeting PKCθ in alloreactivity and graft-versus-host-disease: unanswered questions and therapeutic potential Dahkki Bronk, Crystina C., Yu, Xue-Zhong, Beg, Amer A.

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Clinical Characteristics and Current Interventions in Shock Patients in Chinese Emergency Departments: A Multicenter Prospective Cohort Study

    Clinical Characteristics and Current Interventions in Shock Patients in Chinese Emergency Departments: A Multicenter Prospective Cohort Study Dahkki Guo, Shu-Bin, Chen, Yun-Xia, Yu, Xue-Zhong

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Adenovirus sneak attacks during the H7N9 flu season

    Adenovirus sneak attacks during the H7N9 flu season Dahkki Xu, Jun, Li, Chen, Walline, Joseph, Yu, XueZhong

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice

    Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice Dahkki Wu, Yongxia, Fu, Jianing, Wang, Haizhen, Yu, Xue-Zhong

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice

    Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice Dahkki Bartee, Eric, Bartee, Mee Y, Bogen, Bjarne, Yu, Xue-Zhong

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    T-Cell Metabolism in Hematopoietic Cell Transplantation

    T-Cell Metabolism in Hematopoietic Cell Transplantation Dahkki Nguyen, Hung D., Kuril, Sandeepkumar, Bastian, David, Yu, Xue-Zhong

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease

    The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease Dahkki Bastian, David, Wu, Yongxia, Betts, Brian C., Yu, Xue-Zhong

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Efficient and Selective Prevention of GVHD by Antigen-Specific Induced Tregs via Linked-Suppression in Mice

    Efficient and Selective Prevention of GVHD by Antigen-Specific Induced Tregs via Linked-Suppression in Mice Dahkki Semple, Kenrick, Yu, Yu, Wang, Dapeng, Anasetti, Claudio, Yu, Xue-Zhong

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly

    Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly Dahkki Veerapathran, Anandharaman, Pidala, Joseph, Beato, Francisca, Yu, Xue-Zhong, Anasetti, Claudio

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    CD28 ligation induces transplantation tolerance by IFN-γ–dependent depletion of T cells that recognize alloantigens

    CD28 ligation induces transplantation tolerance by IFN-γ–dependent depletion of T cells that recognize alloantigens Dahkki Yu, Xue-Zhong, Albert, Michael H., Martin, Paul J., Anasetti, Claudio

    Almmustuhtton 2004
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    CD28 Controls Differentiation of Regulatory T Cells from Naive CD4 T Cells

    CD28 Controls Differentiation of Regulatory T Cells from Naive CD4 T Cells Dahkki Guo, Fei, Iclozan, Cristina, Suh, Woong-Kyung, Anasetti, Claudio, Yu, Xue-Zhong

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacity

    STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacity Dahkki Betts, Brian C., Veerapathran, Anandharaman, Pidala, Joseph, Yu, Xue-Zhong, Anasetti, Claudio

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling

    Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling Dahkki Semple, Kenrick, Nguyen, Antony, Yu, Yu, Wang, Honglin, Anasetti, Claudio, Yu, Xue-Zhong

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Bim is required for T-cell allogeneic responses and graft-versus-host disease in vivo

    Bim is required for T-cell allogeneic responses and graft-versus-host disease in vivo Dahkki Yu, Yu, Yu, Jing, Iclozan, Cristina, Kaosaard, Kane, Anasetti, Claudio, Yu, Xue-Zhong

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    LBH589 enhances T-cell activation in vivo and accelerates graft-versus-host disease in mice

    LBH589 enhances T-cell activation in vivo and accelerates graft-versus-host disease in mice Dahkki Wang, Dapeng, Iclozan, Cristina, Liu, Chen, Xia, Changqing, Anasetti, Claudio, Yu, Xue-Zhong

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Regulatory T-Cell Therapy for Graft-versus-host Disease

    Regulatory T-Cell Therapy for Graft-versus-host Disease Dahkki Heinrichs, Jessica, Bastian, David, Veerapathran, Anandharaman, Anasetti, Claudio, Betts, Brain, Yu, Xue-Zhong

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: